Скачать с ютуб Rheonix Market Differentiation в хорошем качестве

Rheonix Market Differentiation

Rheonix, a, molecular diagnostic company is different from competitors by offering a fully automated and multiplexed solution that can use a variety of sample types. The unique design of the Rheonix CARD tests up to four patient samples at a time. This promotes efficient laboratory workflow. In the time it takes a laboratory technician to perform a manual or semi-automated test, Rheonix can do up to 16 tests. This throughput is ideal for most laboratories. The flexibility of the Encompass MDx and CARD allows for rapid development of new assays. Testing performed on the Encompass MDx saves labs money by eliminating wasted time, equipment and consumables. The Rheonix Hi-Fy Microarray gives users the "power of the panel" by generating more data at a lower cost than other methods. A broad range of samples like swabs, whole blood or formalin fixed paraffin embedded tissue can be applied to the CARD. The Rheonix Encompass MDx is designed to deliver complex molecular results in any lab, by any technician, on any shift. Competitors have chosen singular approaches to the molecular diagnostics. Some, like Biofire, have chosen a multiplex approach; others, like Cepheid emphasize throughput. Rheonix does both while containing costs.